- This event has passed.
The Business of Hope: Taking a Groundbreaking Treatment to Market
April 19, 2017 @ 11:30 am - 1:00 pm
The Business of Hope: Taking a Groundbreaking Treatment to Market Featuring Al Hawkins, CEO & Co-Founder, Milo Biotechnology
Wednesday, April 19
11:30am – 1:00pm
1275 Kinnear Rd. | Columbus, OH 43212
Milo Biotechnology works to develop therapies to increase muscle strength and prevent muscle atrophy. These therapies provide individuals affected by Muscular Dystrophy a greater chance to live a normal life, and more importantly, is providing them and their families with hope.
Al Hawkins Co-Founded Milo Biotechnology, a Cleveland, OH based company, in January 2012, based on technology exclusively licensed from Nationwide Children’s Hospital in Columbus, Ohio. Milo is mid-clinical testing and has established clinical proof of concept in two muscular dystrophy indications. Prior to his role with Milo, Al served as VP of Business Development and an initial employee at BioMotiv and also Co-Founded gene therapy company Abeona Therapeutics.
Join us as Hawkins shares his experience building Milo Biotechnology, working with individuals affected with neuromuscular diseases, and how, through these therapies, he is able to enhance the quality of life for those affected.
Rev1’s Founders’ Lunch series features first-hand insights into the triumphs, trials, and tribulations of Rev1 company founding teams. Each luncheon will feature a founding story and tips on a topic, plus delicious food from a local eatery and optional guided tours of the Rev1 Labs facility.
